Serious concerns about Pradaxa’s side effects are underscored by the FDA’s new warning that the blood thinner should not be used to prevent stroke or blood clots in patients with mechanical heart valves, says Driscoll of The Driscoll Firm, LLC. St. Louis, MO (Vocus/PRWEB) January 31, 2013 – John J. Driscoll, a nationally recognized drug […]
Category: Pradaxa
The Chief Judge for both Yaz injury lawsuits and Pradaxa bleeding lawsuits says that litigation is moving forward despite more and more lawsuits being transferred into multi-district litigation (MDL). The Yaz MDL now has 10,484 cases and 12,650 plaintiffs; the Pradaxa MDL stands at 176 cases and has 192 plaintiffs. Very Busy Judge Discusses Yaz […]
Pradaxa, the anticoagulant drug manufactured by Boehringer Ingelheim and approved by the U.S. Food & Drug Administration (FDA) only two years ago, was supposed to be better than Coumadin to control blood clots that could lead to strokes in Americans with an irregular heartbeat known as atrial fibrillation. However, unlike Coumadin, Pradaxa has no known […]
The U.S. Food and Drug Administration issued a new safety announcement on Nov. 2 about the risk of serious bleeding associated with Pradaxa, a blood thinner prescribed to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation, a common heart rhythm abnormality. Since the approval of Pradaxa in October 2010, […]